2-methoxyestriol has been researched along with Endometrial Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brañes, J; Brosens, JJ; Cuello, M; Kato, S; Lange, S; Owen, GI; Sadarangani, A; Villalón, M | 1 |
1 other study(ies) available for 2-methoxyestriol and Endometrial Neoplasms
Article | Year |
---|---|
The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium.
Topics: 17-Hydroxysteroid Dehydrogenases; Antineoplastic Agents; Apoptosis; Caspases; Cell Line; Cell Line, Tumor; Cell Survival; Drug Synergism; Endometrial Neoplasms; Endometrium; Estriol; Estrogens; Female; Humans; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2007 |